Nitric oxide, epileptic seizures, and action of antiepileptic drugs

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 7, 2011, Pages 808-819

  Banach, Monika ^a   Piskorska, Barbara ^a   Czuczwar, Stanisław J ^a,b   Borowicz, Kinga K ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Epilepsy; Nitric oxide; Nitric oxide synthase inhibitors; Seizures

Indexed keywords

1 [2 (TRIFLUOROMETHYL)PHENYL]IMIDAZOLE; 7 NITROINDAZOLE; ANTICONVULSIVE AGENT; ARGININE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; LAMOTRIGINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG POTENTIATION; EXPERIMENTAL ANIMAL; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; REVIEW; SEIZURE; SEIZURE THRESHOLD; TONIC CLONIC SEIZURE;

EID: 81155123365     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152711798072347     Document Type: Review

References (167)

1. Furchgott, R.F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288, 373-6.
2. Ignarro, L.J. Endothelium-derived nitric oxide: actions and properties. FASEB J., 1989, 3, 31-36.
3. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J., 1992, 6, 3051-3064.
4. Molero-Leal, M. Physiological and physiopathological aspects of nitric acid in mammalian tissues. Invest Clin, 1998, 39, 125-154
5. Calabrese, V.; Mancuso, C.; Calvani, M.; Rizzarelli, E.; Butterfield, D.A.; Stella, A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci., 2007, 8, 766-775.
6. http://nobelprize.org/nobel_prizes/medicine/laureates/1998/ (accessed January 10, 2011)
7. Billiar, T.R. Nitric oxide. Novel biology with clinical relevance. Ann Surg., 1995, 221, 339-349.
8. Snyder, S. Nitric oxide: first in a new class of neurotransmitters. Science, 1992, 257, 494-496.
9. Eissa, N.T.; Strauss, A.J.; Haggerty, C.M.; Choo, E.K.; Chu, S.C.; Moss, J. Alternative splicing of human inducible nitric-oxide synthase mRNA. Tissue specific regulation and induction by cytokines. J. Biol. Chem., 1996, 271, 27184-27187.
10. Alderton, W.K.; Cooper, C.E.; Knowles, R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J., 2001, 357, 593-615
11. Elfering, S.L.; Sarkela, T.M.; Giulivi, C. Biochemistry of mitochondrial nitric-oxide synthase. J. Biol. Chem., 2002, 277, 38079-38086.
12. Alvarez, S.; Valdez, L.B.; Zaobornyj, J.T.; Boveris, A. Oxygen dependence of mitchondrial nitric oxide synthase activity. Biochem. Biophys. Res. Commun., 2003, 305, 771-775.
13. Guix, F.X.; Uribesalgo, I.; Coma, M.; Muñoz, F.J. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol., 2005, 76, 126-152.
14. Kishimoto, J.; Spurr, N.; Liao, M.; Lizhi, L.; Emson, P.; Xu, W. Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics, 1992, 14, 802-804.
15. Marsden, P.A.; Heng, H.H.; Scherer, S.W.; Stewart, R.J.; Hall, A.V.; Shi, X.M.; Tsui, L.C.; Schappert, K.T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem., 1993, 268, 17478-17488.
16. Hall, A.V.; Antoniou, H.; Wang, Y.; Cheung, A.H.; Arbus, A.M.;Olson, S.L.; Lu, W.C.; Kau, C.L.; Marsden, P.A. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J. Biol. Chem., 1994, 269, 33082-33090.
17. Robinson, L.J.; Weremowicz, S.; Morton, C.C.; Michel, T. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics, 1994, 19, 350-357.
18. Geller, D.A.; Billiar, T.R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev., 1998, 17, 7-23.
19. Ebadi, M.; Sharma, S.K. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid. Redox Signal., 2003, 5, 319-335.
20. Mungrue, I.N.; Bredt, D.S.; Stewart, D.J.; Husain, M. From molecules to mammals: what's NOS got to do with it? Acta Physiol. Scand., 2003, 179, 123-135.
21. Nagase, S.; Takemura, K.; Ueda, A.; Aoyagi, K.; Kondoh, M.; Koyama, A. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L- arginine. Biochem. Biophys. Res. Commun., 1997, 233, 150-153.
22. Maiese, K.; Boccone, L. Neuroprotection by peptide growth factors against anoxia and nitric oxide toxicity requires modulation of protein kinase C. J. Cereb. Blood Flow Metab., 1995, 15, 440-449.
23. Muller, B.; Kleschyov, A.L.; Alencar, J.L.; Vanin, A.; Stoclet, J.C. Nitric oxide transport and storage in the cardiovascular system. Ann. NY Acad. Sci., 2002, 962, 131-139.
24. Whiteman, M.; Ketsawatsakul, U.; Halliwell, B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann. NY Acad. Sci., 2002, 962, 242-259.
25. Seregélyes, C.; Igamberdiev, A.U.; Maassen, A.; Hennig, J.; Dudits, D.; Hill, R.D. NO-degradation by alfa class 1 hemoglobin (Mhb1): a possible link to PR-1a gene expression in Mhb1-overproducing tobacco plants. FEBS Lett., 2004, 571, 61-66.
26. Hobbs, A.J.; Ignarro, L.J. Nitric oxide-cyclic GMP signal transduction system. Method Enzymol., 1996, 269, 134-148.
27. Dimmler, S.; Zeiher, A.M. Nitric oxide-an endothelial cell survival factor. Cell Death Differ., 1999, 6, 964-968.
28. Kiefer, F.N.; Misteli, H.; Kalak, N.; Tschudin, K.; Fingerle, J.; Van der Kooij, M.; Stumm, M.; Sumanovski, L.T.; Sieber, C.C.; Battegay, E.J. Inhibition of NO biosynthesis, but not elevated blood pressure, reduces angiogenesis in rat models of secondary hypertension. Blood Press., 2002, 11, 116-124.
29. Pacher, P.; Beckman, J.S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev., 2007, 87, 315-424.
30. Vincent, S.R. Nitric oxide neurons and neurotransmission. Prog. Neurobiol., 2010, 90, 246-255.
31. Bishop, A.; Anderson, J.E. NO signaling in the CNS: from the physiological to the pathological. Toxicology, 2005, 208, 193-205.
32. Arzimanoglou, A.; Hirsch, E.; Nehlig, A.; Castelnau, P.; Gressens, P.; Pereira de Vasconcelos; A. Epilepsy and neuroprotection: an illustrated review. Epileptic Disord., 2002, 4, 173-182.
33. Dawson, T.M.; Snyder, S.H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci., 1994, 14, 5147-5159.
34. Rodrigo, J.; Springall, DR.; Uttenthal, O.; Bentura, M.L.; Abadia Molina, F.; Riveros-Moreno, V.; Martinez-Murillo, R.; Polak, J.M.; Moncada, S. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 1994, 345, 175-221.
35. Colasanti, M.; Persichini, T.; Fabrizi, C.; Cavalieri, E.; Venturini, G.; Ascenzi, P.; Lauro, G.M.; Suzuki, H. Expression of a NOS-III-like protein in human astroglial cell culture. Biochem. Biophys. Res. Commun., 1998, 252, 552-555.
36. Calabrese, V.; Butterfield, D.A.; Scapagnini, G.; Stella, A.M.; Maines, M.D. Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid. Redox Signal., 2006, 8, 444-477.
37. Bredt, D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res., 1999, 31, 577-596.
38. Ignarro, L.J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol., 1991, 41, 485-490.
39. Lipton, S.A.; Choi, Y.B.; Sucher, N.J.; Pan, Z.H.; Stamler, J.S. Redox state, NMDA receptors and NO-related species. Trends Pharmacol. Sci., 1996, 17, 186-187.
40. Broillet, M.C. S-Nitrosylation of proteins. Cell. Mol. Life Sci., 1999, 55, 1036-1042.
41. Cassina, A.M.; Hodara, R.; Souza, J.M.; Thomson, L.; Castro, L.; Ischiropoulos, H.; Freeman, B.A.; Radi, R. Cytochrome c nitration by peroxynitrite. J. Biol. Chem., 2000, 275, 21409-21415.
42. Choi, Y.B.; Tenneti, L.; Le, D.A.; Ortiz, J.; Bai, G.; Chen, H.S.;Lipton, S.A. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat. Neurosci., 2000, 3, 15-21.
43. Jaffrey, S.R.; Erdjument-Bromage, H.; Ferris, C.D.; Tempst, P.; Snyder, S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol., 2001, 3, 193-197.
44. Newman, D.K.; Hoffman, S.; Kotamraju, S.; Zhao, T.; Wakim, B.; Kalyanaraman, B.; Newman, P.J. Nitration of PECAM-1 ITIM tyrosines abrogates phosphorylation and SHP-2 binding. Biochem. Biophys. Res. Commun., 2002, 296, 1171-1179.
45. Kim, Y.M.; Talanian, R.V.; Li, J.; Billiar, T.R. Nitric oxide prevents IL-1 beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1 beta-converting enzyme). J. Immunol., 1998, 161, 4122-4128.
46. Mannick, J.B.; Hausladen, A.; Liu, L.; Hess, D.T.; Zeng, M.; Miao, Q.X.; Kane, L.S.; Gow, A.J.; Stamler, J.S. Fas-induced caspase denitrosylation. Science, 1999, 284, 651-654.
47. Brookes, P.S.; Salinas, E.P.; Darley-Usmar, K.; Eiserich, J.P.; Freeman, B.A.; Darley-Usmar, V.M.; Anderson, P.G. Concentration- dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J. Biol. Chem., 2000, 275, 20474-20479.
48. Thippeswamy, T.; McKay, J.S.; Morris, R. Bax and caspases are inhibited by endogenous nitric oxide in dorsal root ganglion neurons in vitro. Eur. J. Neurosci., 2001, 14, 1229-1236.
49. ] Xiong, H.; Yamada, K.; Has, D.; Nabeshima, T.; Enikolopov, G.; Carnahan, J.; Nawa, H. Mutual regulation between the intercellular messengers nitric oxide and brain-derived neurotrophic factor in rodent neocortical neurons. Eur. J. Neurosci., 1999, 11, 1567-1576.
50. Contestabile, A.; Ciani, E. Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochem. Int.,2004, 45, 903-914.
51. Motterlini, R.; Green, C.J.; Foresti, R. Regulation of heme-oxygenase-1 by redox signals involving nitric oxide. Antioxid. Redox Signal., 2002, 4, 615-624.
52. Mancuso, C.; Scapagini, G.; Currò, D.; Giuffrida Stella, A.M.; De Marco, C.; Butterfield, D.A.; Calabrese, V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front. Biosci., 2007, 12, 1107-1123.
53. Bishop, A.; Marquis, J.C.; Cashman, N.R.; Demple, B. Adaptive resistance to nitric oxide in motor neurons. Free Radic. Biol. Med., 1999, 26, 978-986.
54. Bishop, A.; Fung-Yet, S.; Perrella, M.J.; Lee, A.M.; Cashman, N.R.; Demple, B. Decreased resistance to nitric oxide in motor neurons of HO-1 null mice. Biochem. Biophys. Res. Commun., 2004, 325, 3-9.
55. Mollace, V.; Muscoli, C.; Masini, E.; Cuzzocrea, S.; Salvemini, D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol. Rev., 2005, 57, 217-252.
56. Gu, Z.; Kaul, M.; Yan, B.; Kridel, S.J.; Cui, J.; Strongin, A.; Smith, J.W.; Liddington, R.C.; Lipton, S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science, 2002, 297, 1186-1190.
57. Chung, K.K.; Thomas, B.; Li, X.; Pletnikova, O.; Troncoso, J.C.; Marsh, L.; Dawson, V.L.; Dawson, T.M. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science, 2004, 304, 1328-1331.
58. Hara, M.R.; Thomas, B.; Cascio, M.B.; Bae, B.I.; Hester, L.D.; Dawson, V.L.; Dawson, T.M.; Sawa, A.; Snyder, S.H. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc. Natl. Acad. Sci. USA, 2006, 103, 3887-3889.
59. Uehara, T.; Nakamura, T.; Yao, D.; Shi, Z.Q.; Gu, Z.; Ma, Y.; Masliah, E.; Nomura, Y.; Lipton, S.A. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature, 2006, 441, 513-517.
60. Tamir, S.; Lewis, R.S.; de Rojas Walker, T.; Deen, W.M.; Wishnok, J.S.; Tannenbaum, S.R. The influence of delivery rate on the chemistry and biological effects of nitric oxide. Chem. Res. Toxicol., 1993, 6, 895-899.
61. Tamir, S.; Burney, S.; Tannenbaum, S.R. DNA damage by nitric oxide. Chem. Res. Toxicol., 1996, 9, 821-827.
62. Prast, H.; Tran, M.H.; Fischer, H.; Philippu, A. Nitric oxide-induced release of acetylocholine in the nucleus accumbens: role of cyclic GMP, glutamate, and GABA. J. Neurochem., 1998, 71, 266-273.
63. Lonart, G.; Wang, J.; Johnson, K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol., 1992, 220, 271-272.
64. Lorrain, D.S.; Hull, E.M. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport, 1993, 5, 87-89.
65. Feldman, S.; Weidenfeld, J. Involvement of endogenous glutamate in the stimulatory effect of norepinephrine and serotonin on the hypothalamo-pituitary-adrenocortical axis. Neuroendocrinology, 2004, 79, 43-53.
66. Kaehler, S.T.; Singewald, N.; Sinner, C.; Philippu, A. Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res., 1999, 835, 346-349.
67. Getting, S.J.; Segieth, J.; Ahmad, S.; Biggs, C.S.; Whitton, P.S. Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Res., 1996, 717, 196-199.
68. Ohkuma, S.; Katsura, M.; Chen, D.Z.; Narihara, H.; Kuriyama, K. Nitric oxide-evoked [3H] gamma-aminobutyric acid release is mediated by two distinct release mechanisms. Brain Res. Mol. Brain Res., 1996, 36, 137-144.
69. Sequeira, S.M.; Ambrósio, A.F.; Malva, J.O.; Carvalho, A.P.; Carvalho, C.M. Modulation of glutamate release from rat hippocampal synaptosomes by nitric oxide. Nitric Oxide, 1997, 1, 315-329.
70. Boulton, C.L.; Southam, E.; Garthwaite, J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience, 1995, 69, 699-703.
71. Bon, C.L.; Garthwaite, J. On the role of nitric oxide in hippocampal long-term potentiation. J. Neurosci., 2003, 23, 1941-1948.
72. Fisher, R.S; Boas, W.V.E; Blume, W.; Elger, C.; Genton, P; Lee, P; Engel, J. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia, 2005, 46, 470- 472.
73. Scharfman, H.E. The neurobiology of epilepsy. Curr. Neurol. Neurosci. Rep., 2007, 7, 348-354.
74. G-nitroarginine in brain in vitro and in vivo. Biochem. Biophys. Res. Commun., 1991, 176, 1136-1141.
75. Moncada, P.K.; Palmer, R.M.; Higgs, S.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
76. Fewell, J.E.; Johnson, P. Acute increases in blood pressure cause arousal from sleep in lambs. Brain Res., 1994, 311, 259-265.
77. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res., 1993, 72, 387-395.
78. Babbedge, R.C.; Bland-Ward, P.A.; Hart, S.L.; Moore, P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol., 1993, 110, 225-228.
79. Moore, P.K.; Babbedge, R.C.; Wallace, P.; Gaffen, Z.A.; Hart, S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti- nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol., 1993, 108, 296-297.
80. Wolff, D.J.; Gribin, B.J. The inhibition of the constitutive and inducible nitric synthase isoforms by indazole agents. Arch. Biochem. Biophys., 1994, 311, 300-306.
81. Medhurst, A.D.; Greenlees, C.; Parsons, A.A.; Smith, S.J. Nitric oxide synthase inhibitors 7- and 6-nitroindazole relax smooth muscle in vitro. Eur. J. Pharmacol., 1994, 256, R5-R6.
82. Moore, P.K.; Handy, R.L.C. Selective inhibitors of neuronal nitric oxide synthase-is no NOS really good NOS for the nervous system? Trends Pharmacol. Sci., 1997, 18, 204-211.
83. Handy, R.L.; Harb, H.L.; Wallace, P.; Gaffen, Z.; Whitehead, K.J.; Moore, P.K. Inhibition of nitric oxide synthase by 1-(2- trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br. J. Pharmacol., 1996, 119, 423-431.
84. Przegali ski, E.; Baran, L.; Siwanowicz, J. The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci. Lett., 1996, 217, 145-148.
85. G-nitro-L-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice. J. Neural Transm., 1996, 103, 1145-1152.
86. Baran, L.; Siwanowicz, J.; Przegali ski, E. Effect of nitric oxide synthase inhibitors and molsidomine on the anticonvulsant activity of some antiepileptic drugs. Pol. J. Pharmacol., 1997, 49, 363-368.
87. Borowicz, K.K.; Kleinrok, Z.; Czuczwar, S.J. Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs. Eur. J. Pharmacol., 1997, 331, 127-132.
88. uszczki, J.J.; Sacharuk, A.; Wojciechowska, A.; Andres-Mach, M.M.; Dudra-Jastrze{ogonek}bska, M.; Mohamed, M.; Sawicka, K.M.; Kozi ska, J.; Czuczwar, S.J. 7-Nitroindazole enhances dose- dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Pharmacol. Rep., 2006, 58, 660-671.
89. G-nitroarginine methyl esther, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J. Neural Transm., 1998, 105, 1-12.
90. uszczki, J.J.; Czuczwar, M.; Gawlik, P.; Sawiniec-Pó niak, G.; Czuczwar, K.; Czuczwar, S.J. 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J. Neural Transm., 2006, 113, 1157-1168.
91. G-nitro-L-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice. Pharmacol. Rep., 2006, 58, 955-960.
92. Borowicz, K.K.; Kleinrok, Z.; Czuczwar, S.J. 7-Nitroindazole differentially affects the anticonvulsant activity of antiepileptic drugs against amygdala-kindled seizures in rats. Epilepsia, 2000, 41, 1112- 1118.
93. Rundfeldt, C.; Koch, R.; Richter, A.; Mevissen, M.; Gerecke, U.; Löscher, W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure treshold in a cortical stimulation model in rats. Eur. J. Pharmacol., 1995, 274, 73-81.
94. Sardo, P.; Carletti, F.; D'Agostino, S.; Rizzo, V.; Ferraro, G. Involvement of nitric oxide-soluble guanylyl cyclase pathway in the control of maximal dentate gyrus activation in the rat. J. Neural Transm., 2006, 113, 1855-1861.
95. Sardo, P.; Ferraro, G. Modulatory effects of nitric oxide-active drugs on the anticonvulsant activity of lamotrigine in an experimental model of partial complex epilepsy in the rat. BMC Neurosci., 2007, 8,47.
96. Sardo, P.; D'Agostino, S.; Rizzo, V.; Carletti, F.; Lonobile, G.; Ferraro, G. In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs. J. Neural Transm., 2009, 116, 831-839.
97. Seyfried, T.N.; Glaser, G.H. A review of mouse mutants as genetic model of epilepsy. Epilepsia, 1985, 26, 143-150.
98. Faingold, C.L. Neuronal networks in the genetically epilepsy-prone rat. Adv. Neurol., 1999, 79, 311-321.
99. Smith, S.E.; Man, C.M.; Yip, P.K.; Tang, E.; Chapman, A.G.; Meldrum, B.S. Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br. J. Pharmacol., 1996, 119, 165-173.
100. De Sarro, G.; Gareri, P.; Falconi, U.; De Sarro, A. 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur. J. Pharmacol., 2000, 394, 275-288.
101. Osonoe, K.; Mori, N.; Suzuki, K.; Osonoe, M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol- induced seizures in rats. Brain Res., 1994, 663, 338-340.
102. Kaputlu, I.; Uzbay, T. L-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice. Brain Res., 1997, 753, 98-101.
103. Jelenkovi, A.; Jovanovi, M.; Ninkovi, M.; Maksimovi, M.; Bokonji, D.; Boskovi B. Nitric oxide (NO) and convulsions induced by pentylenetetrazol. Ann. NY Acad. Sci., 2002, 962, 296-305.
104. Del-Bel, E.A.; Oliveira, P.R.; Oliveira, J.A.C.; Mishra, P.K.; Jobe, P.C.; Garcia-Cairasco, N. Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz. J. Med. Biol. Res., 1997, 30, 971-979.
105. G-nitro-L-arginine differentially affects glutamate- or kainate- induced seizures. Neuroreport, 1996, 7, 1605-1608.
106. G-nitro-L-arginine on the anticonvulsant action of four second-generation antiepileptic drugs in pententrazole-induced clonic seizures in mice. Pharmacol. Rep., 2007, 59, 467-473.
107. Borowicz, K.K.; uszczki, J.; Kleinrok, Z.; Czuczwar, S.J. 7-nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J. Neural Transm., 2000, 107, 1117-1126.
108. uszczki, J.J.; Szadkowski, M.; Dudra-Jastrz bska, M.; Czernecki, R.; Filip, D.; Misiuta-Krzesi ska, M.; Barcicka-K osowska, B.; Zwoli ski, J. 7-Nitroindazole does not affect the anti-convulsant action of gabapentin and tiagabine in pentylenetetrazole-induced seizures in mice. JPCCR, 2007, 1, 150-154.
109. Han, D.; Yamada, K.; Senzaki, K.; Xiong, H.; Nawa, H.; Nabeshima, T. Involvement of nitric oxide in pentylenetetrazole-induced kindling in rats. J. Neurochem., 2000, 74, 792-798.
110. G-nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur. J. Pharmacol., 1999, 366, 137-142.
111. Fidecka, S. Study on the influence of potent inhibitors of neuronal nitric oxide synthase on the antinociceptive and anticonvulsant activity of benzodiazepines in mice. Pol. J. Pharmacol., 2003, 55, 193-201.
112. Talarek, S.; Fidecka, S. Role of nitric oxide in anticonvulsant effects of benzodiazepines in mice. Pol. J. Pharmacol., 2003, 55, 181-191.
113. uszczki, J.J.; Szadkowski, M.; Zadro niak, A.; Wojda, E.; Dudra-Jastrz bska, M.; Andres-Mach, M. No effect of 7-nitrindazole on the anticonvulsant action of vigabatrin and oxcarbazepine in pentylenetetrazole-induced seizures in mice. JPCCR, 2008, 2, 137-140.
114. Penix, L.P.; Davis, W.; Subramaniam, S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res., 1994, 18, 177-184.
115. Przegali ski, E.; Baran, L.; Siwanowicz, J. The role of nitric oxide in kainate-induced seizures in mice. Neurosci. Lett., 1994, 170, 74-76.
116. Kirkby, R.D.; Forbes, R.A.; Subramaniam, S. Modification of kainate-induced behavioral and electrographic seizures following inhibition of nitric oxide synthase in mice. Epilepsy Res., 1996, 24, 79-90.
117. Kirkby, R.D.; Carroll, D.M.; Grossman, A.B.; Subramaniam, S. Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res., 1996, 24, 91-100.
118. Proctor, M.R.; Fornai, F.; Afshar, J.K.B.; Gale, K. The role of nitric oxide in focally-evoked limbic seizures. Neuroscience, 1997, 76, 1231-1236.
119. De Sarro, G.B.; Donato Di Paola, E.; De Sarro, A.; Vidal, M.J. Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam. Clin. Pharmacol., 1991, 5, 503-511.
120. Rondouin, G.; Bockaert, J.; Lerner-Natoli, M. L-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. Neuroreport, 1993, 4, 1187-1190.
121. Mülsch, A.; Busse, R.; Mordvintcev, P.I.; Vanin, A.F.; Nielsen, E.O.; Scheel-Krüger, J.; Olesen, S.P. Nitric oxide promotes seizure activity in kainate-treated rats. Neuroreport, 1994, 21, 2325-2328.
122. Yasuda, H.; Fujii, M.; Fujisawa, H.; Ito, H.; Suzuki, M. Changes in nitric oxide synthesis and epileptic activity in the contralateral hippocampus of rats following intrahippocampal kainate injection. Epilepsia, 2001, 42, 13-20.
123. Kata, M.; Baran, L.; Siwanowicz, J.; Dziedzicka-Wasylewska, M. Effect of kainic acid and pentetrazole administration on the activity of nitric oxide synthase in the mouse brain. Pol. J. Pharmacol., 1998, 50, 259-264.
124. Radenovic, L.; Vasiljevic, I.; Selakovic, V.; Jovanovic, M. 7-Nitroindazole reduces nitrite concentration in rat brain after intrahippocampal kainate-induced seizure. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2003, 135, 443-450.
125. Byun, J.S.; Lee, S.H.; Jeon, S.H.; Kwon, Y.S.; Lee, H.J.; Kim, S.S.; Kim, Y.M.; Chun, W. Kainic acid-induced neuronal death is attenuated by aminoguanidine but aggravated by L-NAME in mouse hippocampus. Korean J. Physiol. Pharmacol., 2009, 13, 265-271.
126. Rajasekaran, K.; Jayakumar, R.; Venkatachalam, K. Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin- induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs. Brain Res., 2003, 979, 85-97.
127. Starr, M.S.; Starr, B.S. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav., 1993, 45, 321-325.
128. Van Leeuwen, R.; De Vries, R.; Dzoljic, M.R. 7-Nitro indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures. Eur. J. Pharmacol., 1995, 287, 211-213.
129. Tutka, P.; Barczy ski, B.; Arent, K.; Mosiewicz, J.; Mróz, T.; Wielosz, M. Different effects of nitric oxide synthase inhibitors on convulsions induced by nicotine in mice. Pharmacol. Rep., 2007, 59, 259-267.
130. Buisson, A.; Lakhmeche, N.; Verrecchia, C.; Plotkine, M.; Boulu, R.G. Nitric oxide: an endogenous anticonvulsant substance. Neuroreport, 1993, 4, 444-446.
131. G-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6- hydroxydopamine lesions. Eur. J. Pharmacol., 1996, 299, 9-16.
132. Haberny, K.A.; Pou, S.; Eccles, C.U. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci. Lett., 1992, 146, 187-190.
133. Wang, Q.; Theard, M.A.; Pelligrino, D.A.; Baughman, V.L.; Haffman, W.E.; Albrecht, R.F.; Cwik, M.; Paulson O.B.; Lassen, N.A. Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Res., 1994, 658, 192-198.
134. Tutka, P.; M ynarczyk, M.; ó kowska, D.; Kleinrok, Z.; Wielosz, M.; Czuczwar, S.J. Nitric oxide and convulsions in 4-aminopyridine- treated mice. Eur. J. Clin. Pharmacol., 2002, 437, 47-53.
135. Masukawa, T.; Nakanishi, K.; Natsuki, R. Role of nitric oxide in the convulsions following the coadministration of enoxacin with fenbufen in mice. Jpn. J. Pharmacol., 1998, 76, 425-429.
136. Chavko, M.; Xing, G.; Keyser, D.O. Increased sensitivity to seizures in repeated exposures to hyperbaric oxygen: role of NOS activation. Brain Res., 2001, 900, 227-233.
137. Lallement, G.; Shih, T.M.; Pernot-Marino, I.; Baubichon, D.; Foquin, A.; McDonough, J.H. The role of nitric oxide in soman-induced seizures, neuropathology, and lethality. Pharmacol. Biochem. Behav., 1996, 54, 731-737.
138. Matsumura, N.; Kikuchi-Utsumi, K.; Nakaki, T. Activities of 7- nitroindazole and 1-(2-(trilfluoromethylphenyl)-imidazole independent of neuronal nitric-oxide synthase inhibition. J. Pharmacol. Exp. Ther., 2008, 325, 357-362.
139. Riazi, K.; Roshanpour, M.; Rafiei-Tabatabaei, N.; Homayoun, H.; Ebrahimi, F.; Dehpour, A.R. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br. J. Pharmacol., 2006, 147, 935-943.
140. Gholipour, T.; Rasouli, A.; Jabbarzadeh, A.; Nezami, B.G.; Riazi, K; Sharifzadeh, M.; Dehpour, A.R. The interaction of sildenafil with the anticonvulsant effect of diazepam. Eur. J. Pharmacol., 2009, 617, 79-83.
141. Nieoczym, D.; Socała, K.; Rundfeldt, C.; Wla, P. Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in rats. Pharmacol. Rep., 2010, 62, 383-391.
142. Yahyavi-Firouz-Abadi, N.; Tahsili-Fahadan, P.; Riazi, K.; Ghahremani, M.H.; Dehpour, A.R. Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice. Epilepsy Res., 2006, 68, 103-113.
143. Aricioglu, F.; Kan, B.; Yillar, O.; Korcegez, E.; Berkman, K. Effect of agmatine on electrically and chemically induced seizures in mice. Ann. NY Acad. Sci., 2003, 1009, 141-146.
144. uszczki, J.J.; Czernecki, R.; Wojtal, K.; Borowicz, K.K.; Czuczwar, S.J. Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model. J. Neural Transm., 2008, 115, 1485-1494.
145. uszczki, J.J.; Czernecki, R.; Dudra-Jastrz bska, M.; Borowicz, K.K.; Czuczwar, S.J. Influence of agmatine on the protective action of numerous antiepileptic drugs against pententrazole-induced seizures in mice. Pharmacol. Rep., 2009, 61, 252-260.
146. Bahremand, A.; Ziai, P.; Khodadad, T.K.; Payandemehr, B.; Rahimian, R.; Ghasemi, A.; Ghasemi, M.; Hedayat, T.; Dehpour, A.R. Agmatine enhances the anticonvulsant effect of lithium chloride on pentylenetetrazole-induced seizures in mice: involvement of L- arginine/nitric oxide pathway. Epilepsy Behav., 2010, 18, 186-192.
147. Lesani, A.; Javadi-Paydar, M.; Khodadad, T.K.; Asghari-Roodsari, A.; Shirkhodaei, M.; Norouzi, A.; Dehpour, A.R. Involvement of the nitric oxide pathway in the anticonvulsant effect of tramadol on pentylenetetrazole-induced seizures in mice. Epilepsy Behav., 2010, 19, 290-295.
148. Bosnak, M.; Ayyildiz, M.; Yildrim, M.; Agar, E. The role of nitric oxide in the anticonvulsant effects of pyridoxine on penicillin- induced epileptiform activity in rats. Epilepsy Res., 2007, 76, 49-59.
149. Bahremand, A.; Nasrabady, S.E.; Ziai, P.; Rahimian, R.; Hedayat, T.; Payandemehr, B.; Dehpour, A.R. Involvement of nitric oxide-cGMP pathway in the anticonvulsant effects of lithium chloride on PTZ- induced seizure in mice. Epilepsy Res., 2010, 89, 295-302.
150. Khavandgar, S.; Homayoun, H.; Dehpour, A.R. Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice. Pharmacol. Biochem. Behav., 2003, 74, 795-801.
151. Ghasemi, M.; Shafaroodi, H.; Nazarbeiki, S.; Meskar, H.; Ghasemi, A.; Bahremand, A.; Ziai, P.; Dehpour, A.R. Inhibition of NMDA receptor/NO signaling blocked tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice. Epilepsy Res., 2010, 91, 39-48.
152. Aslan, A.; Yildirim, M.; Ayyildiz, M.; Güven, A.; Agar, E. Interaction of leptin and nitric oxide pathway on penicillin-induced epileptiform activity in rats. Brain Res., 2010, 1321, 117-124.
153. Yildrim, M.; Ayyildiz, M.; Agar, E. Endothelial nitric oxide synthase activity involves in the protective effect of ascorbic acid against penicillin-induced epileptiform activity. Seizure, 2010, 19, 102-108.
154. Akula, K.K.; Dhir, A.; Kulkarni, S.K. Nitric oxide signaling pathway in the anticonvulsant effect of adenosine against pentylenetetrazol-induced seizure treshold in mice. Eur. J. Pharmacol., 2008, 587, 129-134.
155. Aslan, A.; Yildrim, M.; Ayyildiz, M.; Güven, A.; Agar, E. The role of nitric oxide in the inhibitory effect of ghrelin against penicillin- induced epileptiform activity in rat. Neuropeptides, 2009, 43, 295-302.
156. Vanhatalo, S.; Riikonen, R. Nitric oxide metabolites, nitrates and nitrites in the cerebrospinal fluid in children with West syndrome. Epilepsy Res., 2001, 46, 3-13.
157. Ikeda, M.; Sato, I.; Matsunaga, T.; Takahashi, M.; Yuasa, T.; Murota, S. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillan-Barré syndrome. Intern. Med., 1995, 34, 734-737.
158. Suzuki, Y.; Osuka, K.; Noda, A.; Tanazawa, T.; Takayasu, M.; Shibuya, M.; Yoshida, J. Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage. Neurosurgery, 1997, 41, 807-812.
159. Khaldi, A.; Chiueh, C.C.; Bullock, M.R.; Woodward, J.J. The significance of nitric oxide production in the brain after injury. Ann. NY Acad. Sci., 2002, 962, 53-59.
160. Leite, J.P.; Chimelli, L.; Terra-Bustamante, V.C.; Costa, E.T.; Assirati, J.A.; de Nucci, G.; Martins, A.R. Loss and sprouting of nitric oxide synthase neurons in the human epileptic hippocampus. Epilepsia, 2002, 43, 235-242.
161. D'Alessio, L.; López-Costa, J.J.; Konopka, H.; Consalvo, D.; Seoane, E.; López, M.E.; Guelman, M.L.; Kochen, S.; Zieher, L.M. NADPH diaphorase reactive neurons in temporal lobe cortex of patients with intractable epilepsy and hippocampal sclerosis. Epilepsy Res., 2007, 74, 228-231.
162. González-Hernández, T.; Garcia-Marin, V.; Pérez-Delgado, M.M.; González-González, M.L.; Rancel-Torres, N.; González-Feria, L. Nitric oxide synthase expression in the cerebral cortex of patients with epilepsy. Epilepsia, 2000, 41, 1259-1268.
163. Carmeli, E.; Beiker, R.; Morad, M. Nitric oxide and interlukin-6 levels in intellectual disability adults with epilepsy. Res. Dev. Disabil., 2009, 30, 567-571.
164. Karabiber, H.; Yakinci, C.; Durmaz, Y.; Temel, I.; Mehmet, N. Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine. Brain Dev., 2004, 26, 15-18.
165. Peker, E.; Oktar, S.; Ari, M.; Kozan, R.; Doǧan, M.; Ça ǧan, E.; Söǧüt, S. Nitric oxide, lipid peroxidation, and antioxidant enzyme levels in epileptic children using valproic acid. Brain Res., 2009, 1297, 194-197.
166. Arhan, E.; Serdaroglu, A.; Ozturk, B.; Ozturk, H.S.; Ozcelik, A.; Kurt, N.; Kutsal, E.; Sevinc, N. Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy. Seizure, 2011, 20, 138-142.
167. Howes, L.G.; Brillante, D.G. Expert opinion on tilarginine in thetreatment of shock.Expert Opin. Investig. Drugs, 2008, 17, 1573-1580.